Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

The COVID-19 pandemic, caused by SARS-CoV-2, is a pressing public health emergency garnering rapid response from scientists across the globe. Host cell invasion is initiated through direct binding of the viral spike protein to the host receptor angiotensin-converting enzyme 2 (ACE2). Disrupting the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:bioRxiv
Huvudupphovsmän: Hanson, Quinlin M., Wilson, Kelli M., Shen, Min, Itkin, Zina, Eastman, Richard T., Shinn, Paul, Hall, Matthew D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Cold Spring Harbor Laboratory 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301901/
https://ncbi.nlm.nih.gov/pubmed/32577632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.06.16.154708
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk